Comparative efficacy and safety of dabrafenib in combination with trametinib versus competing adjuvant therapies for high-risk melanoma

from Journal of Comparative Effectiveness Research at http://bit.ly/37S01OT on November 29, 2019 at 06:14AM


Journal of Comparative Effectiveness Research, Ahead of Print.